Latest

Biotech Jason Mast

STAT Plus: CRISPR? Nah. A new startup bets on an old approach to gene editing

Health Helen Branswell

FDA offers radio silence on question of spring Covid boosters, as other countries push ahead

In the Lab Isabella Cueto

‘That is my dream’: Scientist who uncovered likely leading cause of MS wants to tackle ALS next

Health Tech Lizzy Lawrence

STAT Plus: Momentum grows to subject medical devices to medicine’s gold standard — the placebo treatment

Politics Rachel Cohrs

STAT Plus: The big-money Medicare policy that has hospitals worried this Congress

First Opinion Jeff Levin-Scherz

The Cancer Moonshot will never take off without economists and finance experts

Politics Rachel Cohrs

STAT Plus: Medicare explains how it will choose drugs for negotiation

Politics John Wilkerson

STAT Plus: Would the federal government defer to states to regulate PBMs?

Health Sean Murphy and Matthew Perrone — Associated Press

Texas judge hears arguments in lawsuit to pull long-used abortion pill off the market

First Opinion Podcast Patrick Skerrett and Torie Bosch

Listen: Big changes for First Opinion

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill

Politics Sarah Owermohle and Rachel Cohrs

STAT Plus: HHS chooses a location for ARPA-H — sort of

Politics Rachel Cohrs

STAT Plus: Biden administration to fine manufacturers of 27 medicines for price hikes

Health Sara Van Note

West Nile, Lyme, and other diseases are on the rise with climate change. Experts warn the U.S. is not prepared

First Opinion Smisha Agarwal and Rose Weeks

STAT Plus: AI chatbots can improve health — but only with help from humans

Health Tech Ambar Castillo

STAT Plus: In Minnesota, researchers explore how to audit health AI models on a patient level

First Opinion Brian Finrow, Aleks Engel and Srinivas Akkaraju

STAT Plus: Drug developers navigating ‘biology’s century’ need a model. We made one

Pharmalot Ed Silverman

STAT Plus: Democratic lawmakers press pharmacy chains on abortion pill access

Politics John Wilkerson

STAT Plus: PhRMA chief dings health insurers over drug prices at their own conference

Don't Miss Rick Berke

A letter from the executive editor: The 2023 STATUS List

In the Lab Usha Lee McFarling

National Academies calls for transforming use of racial and ethnic labels in genetics research

Adam's Take Adam Feuerstein

STAT Plus: Amylyx’s ALS drug launch starts strong. That could be trouble for the FDA

Health Brittany Trang

EPA announces proposed drinking water limits for six ‘forever chemicals’

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Novo to cut some insulin prices by up to 75%; Veterans Administration to cover new Alzheimer’s treatment

Pharmalot Ed Silverman

STAT Plus: Novo Nordisk to lower insulin prices by up to 75% amid growing pressure

Politics Nicholas Florko

STAT Plus: ‘Leave the chocolate milk out of this’: School cooks, parents, kids push back on USDA effort to make lunches healthier

In the Lab Megan Molteni

Setting aside the thorniest issues around CRISPR babies, scientists say embryo-editing research should proceed

First Opinion Daniel Fass and David Townsend

NRC: be straight about when clinicians need to report errors that lead to radiation exposure

Health Eric Boodman

‘This is a nonpartisan issue’: Planned Parenthood’s Alexis McGill Johnson on fighting for reproductive rights